GREY:ATBPF - Post by User
Comment by
MrMugsyon Jan 07, 2021 9:13am
182 Views
Post# 32240757
RE:RE:New Hire
RE:RE:New HireForestview wrote: Not sure if this will impact the stock much, but another step in the right direction, I suppose. Looks like AskBio sold it's cell and gene theraphy platform, for $2B upfront, and an additional $2B in milestone success based incentives. They're vague on what those incentives were (or at least I couldn't find them), and since this happened in Oct 2020, no idea if any have been achieved.
What's the group's thoughts on what a potential acquisition would look like for ATE? Would it be a combo cash and incentive deal, given that some of their IP hasn't gone through the drug development phases? Ideally, I think we'd all like to have cash and be done with it, but what's the chances of that?
Yes - step in the right direction. Means things are heating up (to use Dan's words).
Should be positive for the share price ... in combination with a few other initiatives as we get ready for Phase 3.
I still only assume 3-4 partners for OTENA.
Anything more than that (like a buyout of the business) would be a bonus and it would net us a few billion dollars.
Just my opinion.